Rani Therapeutics Holdings

NasdaqGM:RANI Stock Report

Mkt Cap: US$455.9m

Rani Therapeutics Holdings Management

How experienced are the management team and are they aligned to shareholders interests?

1.5yrs

Average management tenure


CEO

Talat Imran (41 yo)

1.25yrs

Tenure

US$12,074,373

Compensation

Mr. Talat Imran has served as Chief Executive Officer and Director of Rani Therapeutics Holdings, Inc. since June 2021 and served as its Vice President of Strategy from January 2014 to June 2021. Mr. Imran...


CEO Compensation Analysis

Compensation vs Market: Talat's total compensation ($USD12.07M) is above average for companies of similar size in the US market ($USD2.78M).

Compensation vs Earnings: Insufficient data to compare Talat's compensation with company performance.


Leadership Team

Experienced Management: RANI's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.


Board Members

Experienced Board: RANI's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.